- Home
- MGN vs MDCX Comparison
MGN vs MDCX Comparison
Compare MGN & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | MGN | MDCX |
|---|---|---|
| Founded | 2020 | 2008 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.0M | 45.2M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | MGN | MDCX |
|---|---|---|
| Price | $2.12 | $2.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.50 |
| AVG Volume (30 Days) | 52.5K | ★ 332.0K |
| Earning Date | 12-19-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $13,484,571.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $29.72 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.30 | $1.68 |
| 52 Week High | $8.63 | $8.94 |
Technical Indicators
Market Signals| Indicator | MGN | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 47.11 |
| Support Level | N/A | $1.68 |
| Resistance Level | N/A | $2.26 |
| Average True Range (ATR) | 0.00 | 0.19 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 42.86 |
Price Performance
Historical ComparisonAbout MGN Megan Holdings Limited Ordinary Shares
Megan Holdings Ltd is principally engaged in the development, construction and maintenance of aquaculture farms and related works. Its operations are based in Malaysia. The company's operating segments include: Aquaculture and agriculture; Industrial solutions; and Investment in marketable securities. It derives maximum revenue from Aquaculture and agriculture, which involves development, construction, and maintenance of aquaculture and agriculture farms and related works.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.